No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
798 |
4. Check minimum number of eventsNone |
798 |
5. Include endpointsNone |
798 |
6. Filter based on genotype QC (FinnGen only) |
772 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F60
- Name in latin
- Personalitas anxifera
Similar endpoints
↥List of similar endpoints to
Anxious personality disorder
based on the number of shared cases.
Similar with more cases:
- Specific personality disorders
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6586 | 3244 | 3328 |
| Only index persons | 6345 | 3173 | 3172 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.09 | 0.09 |
| Only index persons | 0.12 | 0.12 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 31.88 | 31.84 | 31.90 |
| Only index persons | 31.54 | 31.61 | 31.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 772 | 491 | 281 |
| Unadjusted period prevalence (%) | 0.16 | 0.17 | 0.13 |
| Median age at first event (years) | 34.50 | 34.73 | 34.10 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 798
- Matched controls
- 7980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N05AH04
ATC
quetiapine; oral
13.8
321.2
513
922
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
20.5
307.7
324
257
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
28.2
307.7
299
166
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
18.6
307.7
327
287
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
4503599627370496.0
307.7
763
*
F40.1
ICD-10 Finland
Social phobias
26.7
307.7
274
153
N06AX16
ATC
venlafaxine; oral
12.4
291.1
433
699
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.3
266.2
416
704
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
16.3
224.0
212
173
F34.1
ICD-10 Finland
Dysthymia
17.7
220.3
197
145
N05AX12
ATC
aripiprazole; systemic
15.7
217.6
211
179
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
13.2
213.9
237
248
N05AH03
ATC
olanzapine; systemic
12.4
206.3
239
266
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
9.3
191.0
296
476
N06AX12
ATC
bupropion; oral
9.7
185.8
269
398
N06AB06
ATC
sertraline; oral
8.5
185.7
324
594
N06AB04
ATC
citalopram; systemic
7.7
180.7
370
801
N05AX08
ATC
risperidone; systemic
11.7
166.8
194
214
F60.5
ICD-10 Finland
Anankastic personality disorder
61.8
166.2
93
17
N06AB03
ATC
fluoxetine; oral
8.0
157.3
271
482
N06AB10
ATC
escitalopram; oral
6.4
151.5
440
1294
P76
ICPC
Depressive disorder
8.5
149.6
233
369
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.9
139.7
283
589
N06AX11
ATC
mirtazapine; oral
5.9
138.4
485
1652
N05BA04
ATC
oxazepam; oral
5.8
135.5
403
1189
F41.1
ICD-10 Finland
Generalized anxiety disorder
7.9
129.5
211
348
N03AX09
ATC
lamotrigine; oral
10.0
128.5
164
202
N06AX26
ATC
vortioxetine; oral
7.5
127.8
222
392
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
13.9
123.7
121
101
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
39.9
123.3
76
21
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
15.9
112.8
101
72
N05AB03
ATC
perphenazine; systemic, rectal
14.1
109.0
105
85
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.0
108.6
125
133
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
21.4
108.2
83
43
N06AX21
ATC
duloxetine; oral
6.2
106.8
227
484
N06AG02
ATC
moclobemide; oral
12.6
105.3
109
99
F61.0
ICD-10 Finland
Mixed personality disorders
561.0
102.0
99
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
13.1
100.8
101
87
P03
ICPC
Feeling depressed
5.3
100.7
268
695
ZY010
NOMESCO Finland
Hospital outpatient
7.8
98.8
153
235
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
371.1
98.3
97
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.1
97.9
276
749
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
9.1
94.9
126
161
N05AA02
ATC
levomepromazine; systemic
12.7
94.0
96
85
N06AB05
ATC
paroxetine; oral
8.0
91.9
138
204
N06AX03
ATC
mianserin; oral
10.7
90.3
104
110
P99
ICPC
Psychological disorders other
9.9
89.2
109
125
IGY02
NOMESCO Finland
Psychiatric monitoring contact
10.2
88.6
106
118
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
11.4
88.2
97
96
SPAT1240
SPAT
Therapeutic discussion
4.9
87.9
252
687
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
465.3
85.8
84
*
P01
ICPC
Feeling anxious/nervous/tense
4.4
85.7
309
1003
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.1
84.5
123
175
P29
ICPC
Psychological sympt/compl other
5.4
82.5
195
450
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
10.8
79.2
90
93
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
8.8
78.3
105
135
N06AX22
ATC
agomelatine; oral
11.2
75.3
83
82
N05BE01
ATC
buspirone; oral
10.5
74.3
86
91
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
8.9
72.6
96
121
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
8.2
72.4
103
142
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.4
72.3
235
696
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
10.6
71.9
82
85
C07AA05
ATC
propranolol; systemic
3.8
70.6
308
1121
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
25.3
70.5
50
21
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.0
69.1
135
260
N05AF03
ATC
chlorprothixene; systemic
13.0
65.8
65
54
Z2445
NOMESCO Finland
Psychologist
7.0
65.5
108
175
N05AN01
ATC
lithium; oral
10.9
64.6
72
72
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
9.6
62.7
77
88
F60.9
ICD-10 Finland
Personality disorder, unspecified
141.3
61.9
65
5
N03AE01
ATC
clonazepam; systemic
7.3
61.6
96
146
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
16.8
61.1
52
33
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
12.4
60.9
62
54
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.8
60.7
73
81
N05BA01
ATC
diazepam; systemic, rectal
4.6
60.7
168
435
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
7.4
60.7
94
142
N06AX05
ATC
trazodone; oral
10.8
60.1
67
67
N03AG01
ATC
valproic acid; systemic, rectal
6.3
60.0
110
198
AA400
NOMESCO Finland
Electroconvulsive therapy
23.2
60.0
44
20
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
9.8
59.8
72
80
F60.8
ICD-10 Finland
Other specific personality disorders
212.0
57.8
59
*
F60.0
ICD-10 Finland
Paranoid personality disorder
599.1
57.4
56
*
SPAT1307
SPAT
Psychosocial counselling and guidance
4.4
57.1
167
450
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.7
56.8
117
235
N05BA06
ATC
lorazepam; systemic, sublingual
7.7
55.6
82
117
P74
ICPC
Anxiety disorder/anxiety state
5.2
55.3
126
277
N05CD07
ATC
temazepam; oral
5.8
54.5
108
209
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.7
53.9
79
112
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.7
52.6
107
212
F10.20
ICD-10 Finland
Alcohol dependence currently independent
13.2
52.5
51
41
Z2446
NOMESCO Finland
Social worker
5.4
51.4
112
236
IGY99
NOMESCO Finland
Other psychiatric treatment contact
9.0
50.8
65
78
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.5
50.0
105
214
N05CF01
ATC
zopiclone; oral
3.1
48.9
287
1213
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.9
48.0
92
172
F43.1
ICD-10 Finland
Post-traumatic stress disorder
6.4
46.6
82
141
F60.1
ICD-10 Finland
Schizoid personality disorder
+∞
46.3
44
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
8.7
45.8
60
74
N07BB01
ATC
disulfiram; oral
6.5
45.8
79
133
F31.8
ICD-10 Finland
Other bipolar affective disorders
8.8
45.5
59
72
F33.8
ICD-10 Finland
Other recurrent depressive disorders
15.5
45.4
40
27
F60.7
ICD-10 Finland
Dependent personality disorder
+∞
45.2
43
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
11.0
45.0
49
47
F99
ICD-10 Finland
Mental disorder, not otherwise specified
8.5
44.5
59
74
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
8.4
43.1
58
74
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.4
42.5
90
184
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
9.8
42.2
50
54
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
8.9
41.6
53
63
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
9.3
41.5
51
58
F50.9
ICD-10 Finland
Eating disorder, unspecified
10.5
40.1
45
45
N05AH02
ATC
clozapine; systemic
8.3
40.0
54
69
3018C
ICD-9 Finland
Personality disorders, Other personality disorders[ESTYNYT PERSOONALLISUUS]
+∞
39.9
38
*
P72
ICPC
Schizophrenia
8.2
39.5
54
70
F33
ICD-10 Finland
Recurrent depressive disorder
6.9
39.3
63
98
N05AL01
ATC
sulpiride; systemic
15.2
39.3
35
24
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.5
39.2
81
162
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
12.0
39.0
40
35
ZYC01
NOMESCO Finland
Remote contact by phone
4.5
36.9
98
242
F39
ICD-10 Finland
Unspecified mood [affective] disorder
7.5
36.9
54
76
N06AB08
ATC
fluvoxamine; oral
9.3
36.6
45
51
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.8
35.9
86
195
F32.8
ICD-10 Finland
Other depressive episodes
9.1
35.2
44
51
IGY02, ,
SPAT
11.0
35.1
38
36
N05AD01
ATC
haloperidol; systemic
10.2
35.0
40
41
N05AF01
ATC
flupentixol; systemic
13.2
34.2
33
26
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
79.8
34.1
38
5
N05BA12
ATC
alprazolam; oral
3.6
33.4
122
378
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.7
32.8
80
184
IGV01
NOMESCO Finland
Psychiatric network contact
12.3
32.7
33
28
F84.5
ICD-10 Finland
Asperger syndrome
11.4
32.2
34
31
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
12.9
31.7
31
25
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.6
31.2
45
62
N03AX16
ATC
[U] pregabalin
2.8
31.0
200
862
P80
ICPC
Personality disorder
166.5
30.9
32
*
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
10.7
30.9
34
33
SPAT1234
SPAT
Support of social functional capacity
5.8
30.5
58
107
F32
ICD-10 Finland
Depressive episode
3.9
29.9
95
267
F41.00
ICD-10 Finland
Moderate panic disorder
6.5
29.5
49
79
N06AA09
ATC
amitriptyline; systemic
4.0
29.4
88
237
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.1
28.7
44
65
N05CF02
ATC
zolpidem; oral
2.8
28.7
174
724
N06AA12
ATC
doxepin; systemic
5.4
28.5
58
114
P06
ICPC
Sleep disturbance
2.9
28.2
152
593
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
26.5
27.7
38
15
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
6.5
26.4
44
71
SPAT1243
SPAT
Psychiatric/psychological examination
4.7
26.4
63
142
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
9.4
25.8
31
34
P28
ICPC
Limited function/disability (P)
10.3
25.7
29
29
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.4
25.7
67
162
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
6.9
25.3
40
61
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.5
24.7
92
287
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
7.8
24.4
34
45
IBA03
NOMESCO Finland
Psychotherapy evaluation
7.6
24.3
35
48
N06AX18
ATC
reboxetine; oral
23.6
24.1
34
15
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.2
23.9
36
52
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.7
23.8
154
658
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.8
23.7
44
79
OAB43, ,
SPAT
0.4
23.7
130
2721
F32.1
ICD-10 Finland
Moderate depressive episode
3.1
23.5
108
383
N05BA02
ATC
chlordiazepoxide; systemic
8.2
23.1
31
39
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
+∞
23.0
22
*
N05AC02
ATC
thioridazine; oral
7.0
22.7
35
52
Z3231
NOMESCO Finland
Registered nurse
2.3
22.4
227
1187
P27
ICPC
Fear of mental disorder
6.6
21.5
35
55
N06AA04
ATC
clomipramine; systemic
8.5
21.5
28
34
ZY000
NOMESCO Finland
Hospital inpatient
6.8
21.0
33
50
F21
ICD-10 Finland
Schizotypal disorder
25.0
21.0
29
12
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.8
20.8
67
189
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
7.7
20.5
29
39
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.7
20.4
128
536
N06AA06
ATC
trimipramine; systemic
6.0
20.2
36
62
F50.0
ICD-10 Finland
Anorexia nervosa
8.6
20.2
26
31
SPAT1241
SPAT
Extensive assessment of psychosocial situation
6.3
19.5
33
54
H03AA01
ATC
levothyroxine sodium; systemic
2.3
19.2
184
932
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
7.1
19.2
29
42
IBZ08
NOMESCO Finland
Gender identity assessment
+∞
18.8
18
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
7.0
18.8
29
43
F61
ICD-10 Finland
Mixed and other personality disorders
71.7
18.8
21
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
19.9
18.3
27
14
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.2
18.1
76
255
N04AA02
ATC
biperiden; systemic
7.1
17.9
27
39
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
23.4
17.8
25
11
N02BF02
ATC
pregabalin; oral
3.5
17.7
62
185
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
17.7
101
402
N06AX17
ATC
milnacipran; oral
16.1
17.6
28
18
SPAT1301
SPAT
No procedures
2.0
17.4
252
1489
F10.24
ICD-10 Finland
Alcohol depence active use
7.0
17.1
26
38
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
7.7
17.0
24
32
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
22.4
16.9
24
11
L17
ICPC
Foot/toe symptom/complaint
2.0
16.9
231
1336
IHZ05, ,
SPAT
3.1
16.8
72
244
F50.2
ICD-10 Finland
Bulimia nervosa
13.0
16.7
29
23
N05AE04
ATC
ziprasidone; systemic
13.8
16.6
28
21
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
18.4
16.5
25
14
A04
ICPC
Weakness/tiredness general
2.3
16.5
142
685
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
16.4
95
380
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
6.5
16.4
27
43
F51.0
ICD-10 Finland
Nonorganic insomnia
2.1
16.4
184
988
Z08
ICPC
Social welfare problem
7.2
16.2
24
34
N05AD03
ATC
melperone; systemic
25.1
16.1
22
9
T82
ICPC
Obesity
3.6
16.0
55
162
A06AD11
ATC
lactulose; oral
2.9
15.7
79
293
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
15.7
15
*
N05AE05
ATC
lurasidone; oral
26.9
15.6
21
8
F50.3
ICD-10 Finland
Atypical bulimia nervosa
16.4
15.3
24
15
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
15.3
176
951
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
12.1
15.1
27
23
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
14.6
270
1713
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.5
14.6
24
38
A01
ICPC
Pain general/multiple sites
2.7
14.6
83
329
P15
ICPC
Chronic alcohol abuse
4.1
14.6
41
105
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.7
14.4
27
49
SPAT1252
SPAT
Overall medication plan or its review
3.7
14.4
47
134
SPAT1389
SPAT
Visit based on need for special support
3.5
14.3
51
154
F41.3
ICD-10 Finland
Other mixed anxiety disorders
4.3
14.3
37
89
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
6.8
14.1
22
33
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
14.0
114
534
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
13.9
50
152
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
24.3
13.8
19
8
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
10.7
13.8
26
25
SPAT1216
SPAT
Assessment of functional ability
2.6
13.8
85
351
A29
ICPC
General symptom/complaint other
2.4
13.8
98
433
E66.8
ICD-10 Finland
Other obesity
2.9
13.7
65
234
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
13.6
182
1034
F64.0
ICD-10 Finland
Transsexualism
+∞
13.6
13
*
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
26.3
13.4
18
7
K59.0
ICD-10 Finland
Constipation
3.6
13.4
44
126
F41.08
ICD-10 Finland
Mild or other specified panic syndrome
14.1
13.3
22
16
IEY01
NOMESCO Finland
Psychoeducation, individual
9.9
13.3
26
27
F50.1
ICD-10 Finland
Atypical anorexia nervosa
9.6
13.0
26
28
IER01
NOMESCO Finland
Psychoeducation, group
11.8
12.9
23
20
F22.0
ICD-10 Finland
Delusional disorder
11.2
12.6
23
21
SPAT1395
SPAT
Health check-up of persons outside student and working life
4.4
12.5
31
72
F31
ICD-10 Finland
Bipolar affective disorder
5.7
12.5
23
41
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
12.4
54
185
C07AB07
ATC
bisoprolol; oral
1.8
12.2
242
1554
IHZ07, ,
SPAT
16.2
12.2
19
12
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.2
12.1
32
78
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
12.1
161
910
SPAT1310
SPAT
Counselling related to known health issue
1.8
12.0
262
1728
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
12.0
62
234
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
47.4
11.9
14
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
11.9
108
529
R02
ICPC
Shortness of breath/dyspnoea
2.3
11.8
95
442
SPAT1260
SPAT
Consultation of another employee
2.1
11.8
134
715
R96
ICPC
Asthma
2.6
11.8
73
302
S18
ICPC
Laceration/cut
1.7
11.7
307
2131
G47.3
ICD-10 Finland
Sleep apnoea
1.9
11.4
159
911
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.4
11.3
86
1689
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
15.3
11.3
18
12
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.4
11.3
28
65
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.5
11.2
75
321
P58
ICPC
Psychological, Therapeutic counselling/listening
3.6
11.1
36
102
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.3
11.1
41
127
X78
ICD-10 Finland
Intentional self-harm by sharp object
11.4
11.1
20
18
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.1
11.0
23
46
SPAT1263
SPAT
Sampling
1.7
11.0
334
2402
D12
ICPC
Constipation
4.3
10.9
28
67
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
15.8
10.9
17
11
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
15.8
10.9
17
11
N05AA01
ATC
chlorpromazine; systemic, rectal
10.8
10.8
20
19
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
21.8
10.7
15
7
D01
ICPC
Abdominal pain/cramps general
2.1
10.7
117
616
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
10.5
181
1107
ICB06, ,
NOMESCO Finland
14.4
10.5
17
12
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
14.4
10.5
17
12
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
10.5
91
1710
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
10.5
170
1021
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.0
10.4
29
74
N05AX16
ATC
brexpiprazole; oral
16.3
10.4
16
10
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
8.3
10.4
22
27
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
9.7
10.3
20
21
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
19.1
10.3
15
8
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
19.1
10.3
15
8
AA1AD
NOMESCO Finland
CT of head and brain
1.9
10.3
142
810
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.6
10.2
23
31
Z3226
NOMESCO Finland
Physiotherapist
2.0
10.1
125
686
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
10.0
53
202
SPAT1238
SPAT
Brief therapy
3.9
10.0
29
76
N03AX12
ATC
[U] gabapentin; oral
2.0
10.0
111
587
U05
ICPC
Urination problems other
3.5
10.0
34
100
P86
ICPC
Anorexia nervosa/bulimia
12.4
9.9
17
14
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
8.3
9.9
21
26
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
9.9
62
258
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
20.3
9.8
14
7
IHZ04, ,
SPAT
4.8
9.8
22
47
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.3
9.7
37
117
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
13.6
9.7
16
12
A28
ICPC
Limited function/disability NOS
2.5
9.6
63
267
M79.7
ICD-10 Finland
Fibromyalgia
3.2
9.6
37
118
F28
ICD-10 Finland
Other nonorganic psychotic disorders
15.3
9.5
15
10
A10BA02
ATC
metformin; oral
1.9
9.5
145
854
SPAT1284
SPAT
Extensive health certificate
3.3
9.4
35
109
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
9.4
9
*
P98
ICPC
Psychosis NOS/other
8.8
9.3
19
22
N05AB01
ATC
dixyrazine; systemic
10.8
9.3
17
16
ZXY60
NOMESCO Finland
2-person team, nurses
10.8
9.3
17
16
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
9.3
49
1122
T90
ICPC
Diabetes non-insulin dependent
2.0
9.3
112
609
EBA00
NOMESCO Finland
Extraction of tooth
1.6
9.3
316
2312
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
9.3
91
459
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
9.2
88
439
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
7.9
9.2
20
26
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.8
9.1
46
171
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
9.2
9.1
18
20
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
15.8
9.1
14
9
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
7.6
9.0
20
27
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
9.0
132
767
ZXY61
NOMESCO Finland
2-person team, special workers
18.8
9.0
13
7
SPAT1254
SPAT
Administration of medicine
1.9
9.0
113
624
P20
ICPC
Memory disturbance
3.0
8.9
39
134
SPAT1097
SPAT
Recording of ECG
2.2
8.9
77
369
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
8.8
87
439
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
8.7
8.8
18
21
R53
ICD-10 Finland
Malaise and fatigue
1.7
8.8
182
1169
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.4
8.8
61
266
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
7.3
8.8
20
28
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
8.7
172
1092
N05AX15
ATC
cariprazine; oral
11.7
8.6
15
13
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
11.7
8.6
15
13
L28
ICPC
Limited function/disability (L)
2.1
8.6
81
402
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.6
294
2144
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
16.5
8.6
13
8
F50.8
ICD-10 Finland
Other eating disorders
10.2
8.6
16
16
N05AF05
ATC
zuclopenthixol; systemic
10.2
8.6
16
16
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
10.2
8.6
16
16
W78
ICPC
Pregnancy
0.5
8.5
70
1354
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
8.5
77
376
OAA67, ,
SPAT
0.4
8.5
47
1058
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
3.6
8.5
27
76
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
12.9
8.4
14
11
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
8.4
438
3509
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.0
8.3
36
123
S21
ICPC
Skin texture symptom/complaint
1.9
8.3
103
565
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
9.6
8.3
16
17
SPAT1360
SPAT
Extensive global examination
2.6
8.3
48
192
SPAT1058
SPAT
PEF monitoring instruction
2.4
8.3
58
254
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
8.3
132
786
-45
ICPC
Observ/health educat/advice/diet
3.6
8.2
26
73
U04
ICPC
Incontinence urine
3.5
8.1
28
83
T83
ICPC
Overweight
3.8
8.1
24
64
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
8.1
92
1600
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
11.8
8.1
14
12
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
33.7
8.1
10
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
17.4
8.1
12
7
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
8.1
595
5131
N03AF01
ATC
carbamazepine; oral, rectal
3.0
8.1
35
120
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
22.3
8.0
11
5
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
7.9
386
3032
N03AX11
ATC
topiramate; oral
3.2
7.9
31
100
D16
ICPC
Rectal bleeding
3.9
7.8
23
61
SPAT1053
SPAT
Memory test
3.0
7.8
35
122
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
7.8
62
287
Z06
ICPC
Unemployment problem
7.1
7.8
18
26
H13
ICPC
Plugged feeling ear
1.9
7.8
111
637
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
45.4
7.7
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.7
246
1756
WX290
NOMESCO Finland
Other blockage of nerve
1.5
7.7
449
3655
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
7.6
54
238
N05BA05
ATC
potassium clorazepate; oral
12.0
7.6
13
11
Z2221
NOMESCO Finland
Medical doctor
1.6
7.5
197
1340
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
7.5
180
1197
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.2
7.5
61
285
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
7.5
80
1423
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.6
7.5
41
160
N06BA04
ATC
methylphenidate; oral
2.4
7.5
53
234
30088
ICD-8 Finland
Neuroses, Other
80.8
7.4
8
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
80.8
7.4
8
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.4
158
1019
S22
ICPC
Nail symptom/complaint
2.4
7.4
51
222
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
13.5
7.4
12
9
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.8
7.4
22
59
R06.0
ICD-10 Finland
Dyspnoea
1.7
7.4
157
1012
A05
ICPC
Feeling ill
2.0
7.4
83
440
A27
ICPC
Fear of other disease NOS
2.8
7.4
36
132
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
7.4
42
167
U02
ICPC
Urinary frequency/urgency
1.9
7.3
102
581
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
6.9
7.3
17
25
WX882
NOMESCO Finland
High dependency care
4.2
7.3
19
46
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
+∞
7.3
7
*
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
+∞
7.3
7
*
P19
ICPC
Drug abuse
6.3
7.3
18
29
F40.2
ICD-10 Finland
Specific (isolated) phobias
5.9
7.3
19
33
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
5.9
7.3
19
33
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
7.2
54
1085
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.3
7.2
24
682
SPAT1285
SPAT
Provision of consultation response
2.6
7.2
42
169
KMAK, ,
NOMESCO Finland
1.5
7.2
433
3527
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.4
7.2
48
206
SPAT1081
SPAT
Cardiorespiratory global assessment
3.3
7.2
27
85
N05AC01
ATC
periciazine; systemic
30.3
7.2
9
*
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
30.3
7.2
9
*
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
20.2
7.1
10
5
Z91.5
ICD-10 Finland
Personal history of self-harm
20.2
7.1
10
5
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
7.1
606
5308
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
12.2
7.1
12
10
R05
ICPC
Cough
1.6
7.1
181
1222
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.5
7.1
58
1128
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
7.1
270
2000
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
10.1
7.0
13
13
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
7.0
43
177
L02
ICPC
Back symptom/complaint
1.9
7.0
90
499
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.8
7.0
104
605
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.5
7.0
51
1034
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
7.0
37
142
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.9
345
2698
SPAT1370
SPAT
Other health check-up
2.9
6.9
32
114
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
13.9
6.9
11
8
X84
ICD-10 Finland
Intentional self-harm by unspecified means
13.9
6.9
11
8
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.4
6.9
30
750
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
8.4
6.8
14
17
A10BJ06
ATC
semaglutide; parenteral
2.8
6.8
34
126
F45.0
ICD-10 Finland
Somatization disorder
9.4
6.8
13
14
SFA10
NOMESCO Finland
One-surface restoration
1.5
6.8
462
3840
Z2230
NOMESCO Finland
Head nurse
40.4
6.8
8
*
IFB04
NOMESCO Finland
Transcranial direct current stimulation (tDCS)
40.4
6.8
8
*
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.9
6.7
19
49
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.5
6.7
23
68
SPAT1379
SPAT
Health check-up of pregnant person
0.4
6.7
46
957
R11
ICD-10 Finland
Nausea and vomiting
2.0
6.7
69
354
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
6.7
77
411
L84
ICPC
Back syndrome without radiat pain
2.5
6.7
42
175
A11
ICPC
Chest pain NOS
2.3
6.7
48
213
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
22.7
6.7
9
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
22.7
6.7
9
*
V03AA01, ,
ATC
7.9
6.6
14
18
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
6.6
48
214
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
12.4
6.6
11
9
R33
ICD-10 Finland
Retention of urine
2.9
6.6
30
106
SPAT1312
SPAT
General health counselling
1.5
6.6
251
1853
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
8.8
6.6
13
15
A02BC05
ATC
esomeprazole; systemic
1.5
6.6
255
1890
B03BA03
ATC
hydroxocobalamin; parenteral
3.1
6.6
27
90
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
6.9
6.5
15
22
P18
ICPC
Medication abuse
6.9
6.5
15
22
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
6.9
6.5
15
22
R06.5
ICD-10 Finland
Mouth breathing
2.0
6.5
68
351
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
6.5
75
401
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
6.3
6.5
16
26
RD210, ,
NOMESCO Finland
3.6
6.5
21
60
T07
ICPC
Weight gain
3.6
6.5
21
60
SPAT1139
SPAT
Nutrition survey
3.4
6.5
23
70
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
6.4
39
160
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
6.4
60
297
F20
ICD-10 Finland
Schizophrenia
7.5
6.4
14
19
SPAT1380
SPAT
Postpartum check-up
0.4
6.4
34
782
Z28
ICPC
Limited function/disability (Z)
14.4
6.4
10
7
Z50.1
ICD-10 Finland
Other physical therapy
2.7
6.4
33
125
S10
ICPC
Boil/carbuncle
2.3
6.4
48
218
Z03
ICPC
Housing/neighbourhood problem
9.4
6.3
12
13
OAA80, ,
SPAT
0.4
6.3
24
638
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
6.3
37
150
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.6
6.3
36
144
F64.8
ICD-10 Finland
Other gender identity disorders
+∞
6.3
6
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
6.3
6
*
SPAT1153
SPAT
Removal of sutures
1.6
6.2
173
1188
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
26.9
6.2
8
*
L03
ICPC
Low back symptom/complaint
1.5
6.2
207
1481
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.2
6.2
24
77
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.0
6.2
17
43
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.6
6.2
20
57
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
5.8
6.2
16
28
L12
ICPC
Hand/finger symptom/complaint
1.7
6.1
124
789
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
10.1
6.0
11
11
A62
ICPC
General and Unspecified, Administrative procedure
3.5
6.0
20
58
K08.3
ICD-10 Finland
Retained dental root
2.3
6.0
46
210
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
291
1050
3.79
67.07
2.3
1.7
1.59
1.39
%
3.97
263
965
398
1830
3.34
61.39
2.1
1.7
98.11
97.52
pmol/l
0.08
228
967
208
655
3.94
57.54
1.7
1.6
1089.10
1163.19
nmol/l
0.57
171
514
425
2284
2.84
45.82
6.1
5.9
1.21
1.22
mmol/l
0.66
373
1977
391
2036
2.80
44.42
5.3
5.1
1.21
1.22
mmol/l
0.75
357
1884
243
990
3.09
43.41
1.6
1.4
19.96
21.08
nmol/l
0.49
221
867
691
5034
3.78
39.38
5.2
3.7
14.23
14.47
pmol/l
1.80
658
4661
381
2088
2.58
37.26
4.4
3.1
30.96
30.78
u/l
0.04
361
1988
303
1536
2.57
34.29
3.2
3.2
7.35
8.59
mmol/l
3.86
265
1362
366
2032
2.48
33.99
5.1
4.5
37.29
37.12
g/l
0.22
335
1912
308
1606
2.49
32.47
2.7
3.0
2.35
2.36
mmol/l
0.21
278
1456
36
37
10.14
31.41
2.9
2.8
47963.89
38227.03
ug/l
1.28
36
37
604
4310
2.65
31.02
7.3
6.5
74.46
73.36
u/l
0.37
571
4074
395
2353
2.34
30.30
2.8
2.3
68.83
73.06
nmol/l
2.00
372
2178
738
5925
4.27
29.58
6.4
4.3
1.75
2.17
mu/l
0.85
709
5602
755
6217
4.98
27.82
15.6
9.7
139.64
139.61
mmol/l
0.13
737
6044
253
1285
2.42
27.44
2.3
2.0
2.56
2.73
mg/l
0.73
217
1098
755
6246
4.87
26.97
15.5
9.7
3.88
3.92
mmol/l
3.96
734
6056
723
5849
3.51
26.01
5.0
3.3
5.86
5.69
mmol/l
2.24
686
5476
141
559
2.85
25.22
1.7
2.0
354.09
379.12
nmol/l
0.80
129
520
253
1349
2.28
24.03
3.8
3.0
1.02
1.02
kg/l
0.70
30
185
192
930
2.40
22.61
1.8
1.5
420.85
22196134.61
pmol/l
1.06
168
838
287
1689
2.09
20.68
3.3
2.4
69.81
58.10
u/l
0.35
263
1579
134
583
2.56
19.69
5.1
5.6
1.06
1.04
mmol/l
0.44
124
545
606
4722
2.18
19.48
4.5
2.7
38.14
37.61
u/l
0.10
583
4534
399
2735
1.92
17.87
5.5
5.3
9.92
10.56
umol/l
0.40
376
2583
444
3169
1.90
17.40
4.9
4.0
6.36
6.40
mmol/l
0.13
413
2865
444
3189
1.88
16.85
3.1
2.7
85.99
86.85
ug/l
0.03
416
3022
569
4433
1.99
16.84
4.1
3.6
10.75
8.65
mm/h
3.58
533
4140
235
1386
1.99
16.12
2.5
2.0
184.40
215.53
u/l
0.26
221
1321
474
3510
1.86
15.99
12.0
8.3
3.98
3.98
e9/l
0.02
414
3098
145
724
2.23
15.41
3.1
3.2
0.82
0.82
mmol/l
0.06
135
684
36
81
4.61
15.08
2.6
2.2
—
—
—
0
0
134
667
2.21
14.29
2.3
2.1
2.45
2.43
g/l
0.09
120
620
141
719
2.17
14.15
2.6
2.2
15.20
14.64
umol/l
0.34
132
674
767
6913
3.82
13.76
11.7
8.0
28.94
27.64
u/l
0.77
753
6721
632
5278
1.95
13.06
5.7
4.2
37.89
38.00
mmol/mol
0.09
595
5040
24
23
10.72
12.81
7.3
1.7
158.23
167.73
umol/l
0.04
13
11
120
607
2.15
12.20
2.3
2.2
27.06
24.43
%
0.81
98
530
111
546
2.20
12.10
9.9
5.4
—
—
—
0
0
90
410
2.35
11.77
7.0
8.5
1.63
0.88
mmol/l
1.35
72
316
264
1770
1.73
11.33
1.4
1.3
3.08
1.57
u/ml
0.38
56
494
200
1239
1.82
11.25
3.4
4.0
23.04
13.63
mg/mmol
0.50
114
810
192
1177
1.83
11.16
3.2
3.4
1270.85
191.47
mg/l
0.92
106
788
102
504
2.17
10.97
6.8
6.1
104.26
104.55
mmol/l
0.24
102
504
285
1967
1.70
10.93
11.5
7.8
1.06
1.10
inr
0.46
59
652
92
440
2.23
10.72
2.1
1.5
396.62
294.42
mu/l
1.35
77
393
225
1466
1.74
10.57
1.9
1.6
1.55
1.43
mmol/l
0.77
199
1278
90
434
2.21
10.27
2.8
2.3
0.22
0.24
g/l
1.33
77
409
704
6248
2.08
10.21
4.8
3.7
2.85
2.88
mmol/l
0.32
661
5937
60
244
2.58
10.01
2.1
2.5
98.98
119.41
ng/l
0.24
52
212
134
760
1.92
9.84
2.4
2.4
2.42
2.42
mmol/l
0.11
117
657
229
1536
1.69
9.54
1.4
1.4
2.10
2.15
g/l
0.17
125
993
698
6213
1.99
9.47
4.5
3.5
4.69
4.76
mmol/l
1.12
666
5938
693
6185
1.92
8.87
4.3
3.4
1.38
1.46
mmol/l
4.56
652
5901
56
235
2.49
8.77
4.9
2.9
130.71
134.37
g/l
0.52
56
230
75
365
2.16
8.36
4.8
3.3
2.22
1.73
mmol/l
0.57
68
302
140
854
1.78
8.07
3.2
3.0
173.30
790.81
ng/l
1.75
80
508
386
3029
1.53
7.96
7.1
5.3
55.24
56.15
%
0.90
366
2883
389
3062
1.53
7.88
7.2
5.5
29.99
29.66
%
0.24
368
2922
73
365
2.10
7.60
5.3
6.1
1.43
1.41
mmol/l
0.04
73
352
663
5916
1.71
7.47
3.8
3.2
1.43
1.26
mmol/l
6.13
618
5632
500
5745
0.65
7.44
3.2
3.7
—
—
—
0
0
481
3999
1.51
7.27
4.5
3.5
2437.25
506.77
e6/l
0.37
12
40
63
308
2.14
6.96
3.4
4.0
83.88
73.73
ng/l
0.42
57
280
713
6534
1.86
6.82
14.1
9.8
20.96
20.24
mg/l
0.22
523
5008
56
274
2.12
6.19
2.7
2.2
4.18
8.40
ug/l
1.62
48
246
112
697
1.71
5.96
1.8
1.7
—
—
—
0
0
45
902
0.47
5.93
1.3
1.5
—
—
—
0
0
68
365
1.94
5.85
1.5
1.9
3.02
3.45
mg/l
0.30
56
251
653
5906
1.58
5.81
18.1
11.8
14.25
14.04
%
0.50
645
5813
63
331
1.98
5.77
1.5
1.6
—
—
—
0
0
787
7567
3.90
5.55
23.7
14.2
40.98
40.95
%
0.08
708
7199
12
17
7.15
5.45
1.9
2.2
15.45
16.85
umol/l
0.15
12
17
787
7575
3.83
5.37
23.7
14.2
4.61
4.60
e12/l
0.12
771
7407
49
919
0.50
5.30
1.4
1.5
—
—
—
0
0
786
7565
3.59
5.25
24.0
14.3
265.16
258.53
e9/l
2.03
772
7407
787
7581
3.77
5.24
23.9
14.3
137.24
137.77
g/l
0.51
780
7499
88
535
1.72
5.09
2.3
2.2
11.18
13.58
nmol/l
1.69
77
507
102
650
1.65
4.96
2.2
2.3
9.26
6.71
umol/l
0.44
86
548
80
480
1.74
4.85
1.9
1.6
—
—
—
0
0
79
474
1.74
4.79
1.8
1.5
—
—
—
0
0
141
981
1.53
4.73
2.4
2.5
88.69
110.45
ug/g
0.56
107
776
39
185
2.17
4.71
5.0
2.3
0.65
0.66
%
0.05
39
185
237
1836
1.41
4.57
3.1
2.7
—
—
—
0
0
130
910
1.51
4.23
2.5
2.8
1876.54
831.42
ng/l
0.51
100
731
76
468
1.69
4.22
1.0
1.0
—
—
—
0
0
32
149
2.20
4.07
1.7
1.4
528.11
316.31
ug/g
0.39
16
78
47
254
1.90
4.02
2.2
2.4
1.25
1.33
mmol/l
0.03
30
173
144
1047
1.46
3.87
2.4
2.2
6.83
7.80
e6/l
0.29
132
935
98
663
1.55
3.73
1.7
1.9
28.79
29.31
s
0.54
93
643
10
20
5.05
3.69
1.0
1.3
71.91
73.10
nmol/24h
—
10
20
179
1366
1.40
3.68
3.7
3.2
93.81
96.26
%
0.66
173
1321
69
431
1.66
3.65
2.1
3.6
4.42
4.67
pmol/l
1.51
62
392
46
257
1.84
3.58
1.7
1.8
—
—
—
0
0
17
404
0.41
3.51
1.8
1.7
—
—
—
0
0
86
578
1.55
3.38
3.5
3.3
31.66
31.37
%
0.09
73
429
26
515
0.49
3.34
1.1
1.5
—
—
—
0
0
17
394
0.42
3.32
1.4
2.0
—
—
—
0
0
170
1309
1.38
3.29
2.1
2.2
2280.99
4996.77
umol/l
0.63
157
1206
14
349
0.39
3.25
1.7
1.5
—
—
—
0
0
23
466
0.48
3.16
1.1
1.4
—
—
—
0
0
23
466
0.48
3.16
1.1
1.4
—
—
—
0
0
23
465
0.48
3.14
1.1
1.4
—
—
—
0
0
23
464
0.48
3.12
1.1
1.4
—
—
—
0
0
53
324
1.68
3.07
1.4
1.4
6.55
8.37
u/l
0.86
45
270
33
585
0.55
3.00
1.5
1.4
—
—
—
0
0
54
335
1.66
2.97
2.6
3.2
1.22
1.23
mmol/l
0.16
42
294
216
1754
1.32
2.92
3.8
2.7
21.08
38.08
ng/l
0.79
106
858
66
434
1.57
2.88
1.6
1.3
14.58
19.67
iu/l
0.90
48
365
113
830
1.42
2.88
2.0
2.2
1.25
1.00
e6/l
0.19
61
442
637
5955
1.35
2.86
10.7
8.3
97.33
94.51
ml/min/173m2
2.46
495
4751
18
77
2.37
2.83
1.7
1.4
—
—
—
0
0
60
390
1.58
2.76
2.2
2.0
75.80
78.36
ml/min/173m2
0.14
25
149
356
3110
1.26
2.67
3.6
2.9
0.00
0.00
estimate
0.50
50
651
6
11
5.49
2.54
1.0
1.0
6.78
7.28
nmol/l
—
6
11
84
599
1.45
2.52
2.5
2.3
3150.57
4329.33
u/l
0.19
18
243
27
144
1.91
2.49
3.3
2.0
4.33
3.23
ug/l
0.14
27
133
15
63
2.41
2.47
1.1
1.3
—
—
—
0
0
15
64
2.37
2.40
1.1
1.1
—
—
—
0
0
190
1555
1.29
2.39
2.8
2.6
32.42
54.74
e6/l
0.50
142
1166
174
1408
1.30
2.38
2.5
2.6
0.30
0.33
e6/l
0.10
128
1038
77
547
1.45
2.37
2.5
2.3
28.25
124.25
u/l
0.55
68
458
14
59
2.40
2.30
1.1
1.0
—
—
—
0
0
82
593
1.43
2.30
1.2
1.2
83.83
140.00
iu/ml
1.17
28
229
49
320
1.57
2.25
1.4
1.3
—
—
—
0
0
354
3138
1.23
2.20
3.7
3.0
0.00
0.00
estimate
0.50
44
606
25
436
0.56
2.20
1.4
1.6
—
—
—
0
0
141
1128
1.30
2.10
2.3
2.0
—
—
—
0
0
17
82
2.10
2.08
1.9
2.0
16.54
16.97
%
0.19
12
43
42
270
1.59
2.07
2.1
2.9
67.65
68.44
g/l
0.37
37
250
25
139
1.82
2.07
1.2
1.3
2.67
8.64
e6/l
1.31
18
107
25
139
1.82
2.07
1.3
1.3
1185.42
629.79
e6/l
0.17
19
112
350
3115
1.22
2.06
4.8
4.1
0.00
0.00
estimate
0.50
50
637
38
239
1.62
2.05
2.9
2.2
0.05
0.14
e6/l
1.66
38
228
25
142
1.79
1.95
1.8
1.4
23.13
18.42
u/l
0.24
20
119
11
45
2.46
1.93
2.1
1.5
—
—
—
0
0
13
58
2.26
1.91
1.8
1.4
—
—
—
0
0
13
58
2.26
1.91
1.8
1.4
—
—
—
0
0
5
12
4.19
1.82
2.2
2.3
—
—
—
0
0
5
12
4.19
1.82
2.2
2.3
—
—
—
0
0
43
288
1.52
1.81
1.8
1.4
—
—
—
0
0
11
48
2.31
1.71
1.1
1.6
—
—
—
0
0
7
25
2.82
1.65
1.7
2.3
—
—
—
0
0
193
1651
1.22
1.63
4.3
3.1
0.00
0.01
estimate
1.28
48
620
5
14
3.59
1.61
2.0
2.1
—
—
—
0
0
14
71
1.99
1.54
1.1
1.4
—
—
—
0
0
14
71
1.99
1.54
1.1
1.4
—
—
—
0
0
99
791
1.29
1.52
2.1
2.3
5.62
3.44
e6/l
0.55
47
406
14
72
1.96
1.49
1.1
1.4
—
—
—
0
0
196
1694
1.21
1.49
2.5
2.2
—
—
—
0
0
18
102
1.78
1.45
3.8
2.5
—
—
—
0
0
9
39
2.32
1.43
1.1
1.7
—
—
—
0
0
28
181
1.57
1.42
1.6
1.9
—
—
—
0
0
27
173
1.58
1.41
1.4
1.5
0.29
0.38
nmol/l
0.67
18
146
110
901
1.26
1.39
2.2
1.9
—
—
—
0
0
30
199
1.53
1.36
2.1
1.8
191.87
227.57
pmol/l
1.07
30
191
5
18
2.79
1.28
2.0
1.3
10.20
16.83
u/l
—
5
18
15
84
1.80
1.27
1.2
1.2
—
—
—
0
0
18
107
1.70
1.26
1.7
1.5
—
—
—
0
0
14
77
1.83
1.26
1.4
1.3
—
—
—
0
0
17
277
0.61
1.24
1.9
1.5
—
—
—
0
0
8
36
2.23
1.24
1.4
1.7
—
—
—
0
0
8
36
2.23
1.24
1.4
1.7
—
—
—
0
0
8
36
2.23
1.24
1.4
1.7
—
—
—
0
0
13
70
1.87
1.24
2.0
1.3
—
—
—
0
0
13
70
1.87
1.24
1.2
1.4
—
—
—
0
0
11
56
1.98
1.22
2.1
1.4
—
—
—
0
0
5
19
2.64
1.21
1.8
1.3
10.14
8.79
ug/l
—
5
19
13
71
1.84
1.20
1.2
1.4
—
—
—
0
0
13
71
1.84
1.20
1.2
1.4
—
—
—
0
0
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
0
35
0.00
1.15
0.0
1.2
—
—
—
0
0
5
20
2.51
1.15
1.0
2.6
2.01
1.22
ug/l
—
5
20
25
170
1.49
1.06
1.6
1.8
—
—
—
0
0
14
82
1.72
1.05
1.7
1.5
—
—
—
0
0
14
82
1.72
1.05
1.7
1.5
—
—
—
0
0
14
227
0.61
1.03
1.5
1.3
—
—
—
0
0
15
91
1.66
1.01
1.0
1.1
—
—
—
0
0
18
116
1.56
0.97
1.1
1.1
1.00
143.13
iu/ml
—
6
35
10
54
1.86
0.97
1.2
1.3
—
—
—
0
0
54
428
1.28
0.94
1.6
1.7
—
—
—
0
0
206
1862
1.14
0.90
2.5
2.3
—
—
—
0
0
13
80
1.64
0.85
1.0
1.1
—
—
—
0
0
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
6
31
1.94
0.84
1.5
1.8
—
—
—
0
0
266
2455
1.13
0.84
4.0
2.9
—
—
—
0
0
8
141
0.56
0.83
1.0
1.1
—
—
—
0
0
17
113
1.52
0.82
1.6
1.5
—
—
—
0
0
17
113
1.52
0.82
4.6
3.1
14.29
25.10
mg/l
—
8
67
10
58
1.73
0.80
1.0
1.4
—
—
—
0
0
6
33
1.82
0.79
2.2
2.2
58.67
50.61
umol/l
—
6
28
13
82
1.60
0.78
1.0
1.1
—
—
—
0
0
123
1086
1.16
0.76
3.0
3.3
1.25
1.76
ug/l
0.92
111
1012
9
54
1.67
0.74
1.6
2.7
0.24
0.21
e9/l
—
9
49
123
1088
1.15
0.74
1.3
1.2
12.45
9.15
u/ml
0.17
32
455
9
56
1.61
0.72
1.6
2.7
453.00
579.43
e6/l
—
9
49
127
1129
1.15
0.72
1.4
1.2
18.74
26.90
iu/ml
0.78
42
362
9
57
1.59
0.71
1.1
1.2
—
—
—
0
0
18
126
1.44
0.70
1.2
1.3
—
—
—
0
0
7
41
1.71
0.70
1.4
2.7
—
—
—
0
0
32
408
0.78
0.69
1.5
1.3
210.86
246.48
miu/ml
0.25
12
209
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
7
44
1.60
0.65
1.0
1.0
—
—
—
0
0
25
189
1.33
0.65
1.1
1.1
—
—
—
0
0
10
63
1.59
0.62
1.1
1.3
—
—
—
0
0
25
191
1.32
0.61
1.1
1.1
—
—
—
0
0
15
105
1.44
0.60
1.9
1.9
5.85
5.25
mmol/24h
0.23
15
97
11
72
1.54
0.59
1.3
1.9
—
—
—
0
0
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
7
115
0.61
0.58
1.4
1.2
—
—
—
0
0
54
633
0.84
0.57
2.2
2.3
0.51
0.64
ug/l
0.43
35
309
5
87
0.57
0.56
1.0
1.6
—
—
—
0
0
11
73
1.51
0.56
1.0
1.1
—
—
—
0
0
8
122
0.65
0.55
1.3
1.1
—
—
—
0
0
96
856
1.14
0.55
3.0
3.1
19.57
22.17
%
0.52
17
271
149
1372
1.11
0.50
1.6
1.7
0.86
0.90
mg/l
0.12
102
976
7
46
1.53
0.48
1.4
1.2
—
—
—
0
0
11
76
1.45
0.48
1.6
1.5
—
—
—
0
0
17
221
0.76
0.46
1.2
1.1
—
—
—
0
0
28
228
1.24
0.45
1.4
1.5
—
—
—
0
0
56
492
1.15
0.42
1.3
1.3
96.92
288.69
u/ml
2.46
49
456
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
16
124
1.30
0.39
2.1
4.9
—
520.07
—
0
14
22
179
1.24
0.37
1.2
1.2
—
—
—
0
0
11
147
0.74
0.37
1.1
1.1
—
9.64
—
0
15
5
37
1.35
0.37
4.0
3.8
442.60
640.97
u/ml
—
5
37
12
90
1.34
0.36
1.2
1.3
—
—
—
0
0
12
90
1.34
0.36
1.2
1.3
—
—
—
0
0
5
80
0.62
0.35
1.2
1.1
—
—
—
0
0
15
189
0.79
0.34
1.3
2.1
5.91
4.48
umol/l
—
9
146
48
425
1.14
0.34
1.3
1.2
—
33.89
—
0
21
57
511
1.12
0.33
1.2
1.3
—
—
—
0
0
15
186
0.80
0.31
1.3
2.0
—
—
—
0
0
7
97
0.72
0.31
1.0
1.1
—
—
—
0
0
7
100
0.70
0.30
3.0
1.7
40.91
40.02
g/l
—
7
94
16
129
1.25
0.30
1.1
1.3
—
1.48
—
0
11
8
106
0.75
0.29
5.3
1.9
0.24
1.05
g/l
—
8
99
8
108
0.74
0.29
2.0
1.2
—
—
—
0
0
16
195
0.82
0.29
2.2
2.0
2.97
5.89
iu/l
—
8
72
8
64
1.25
0.27
1.0
1.3
—
—
—
0
0
8
65
1.23
0.27
1.0
1.3
—
—
—
0
0
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
9
73
1.24
0.25
1.2
1.4
143.04
174.14
pmol/l
—
9
73
24
207
1.16
0.25
1.3
2.0
—
—
—
0
0
5
38
1.32
0.23
1.8
2.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
—
92.60
—
0
5
19
221
0.86
0.22
1.1
1.1
0.15
4.08
u/ml
—
9
113
14
167
0.84
0.21
1.3
1.4
143.50
157.65
pmol/l
0.04
14
162
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
4.7
—
—
—
0
0
5
43
1.16
0.21
1.0
1.7
—
—
—
0
0
20
173
1.16
0.21
1.3
1.2
218.64
230.27
u/ml
0.08
11
105
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
9
115
0.78
0.20
2.3
2.0
—
1360.00
—
0
8
6
52
1.15
0.19
2.5
1.2
—
210.91
—
0
11
15
128
1.18
0.18
1.1
1.2
—
—
—
0
0
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
7
61
1.15
0.17
1.0
1.2
—
—
—
0
0
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
8
70
1.14
0.16
1.1
1.5
—
—
—
0
0
8
70
1.14
0.16
1.1
1.3
—
—
—
0
0
13
111
1.17
0.16
3.3
1.7
10.21
10.54
g/l
0.11
13
104
10
83
1.21
0.15
4.1
3.9
29.17
33.68
mg/l
—
10
67
284
2899
0.97
0.15
2.9
2.4
—
—
—
0
0
9
83
1.09
0.14
4.4
3.9
23.09
28.22
mg/l
—
9
66
11
93
1.19
0.14
1.5
3.3
—
3153.67
—
0
9
11
126
0.87
0.11
1.9
1.5
—
—
—
0
0
48
455
1.06
0.11
2.9
2.4
—
—
—
0
0
33
310
1.07
0.10
1.4
1.4
—
—
—
0
0
5
44
1.14
0.10
4.2
1.9
103.40
105.61
mmol/l
—
5
44
36
342
1.06
0.08
2.2
4.4
6.34
19.10
ug/l
0.48
27
271
18
166
1.09
0.08
1.2
1.3
—
3.14
—
0
20
196
1991
0.98
0.07
1.9
1.6
—
—
—
0
0
8
78
1.03
0.07
1.4
3.3
2.34
7.69
u/ml
—
8
78
7
84
0.83
0.07
1.1
1.1
107.00
94.13
%
—
7
78
7
85
0.82
0.07
1.9
2.2
—
—
—
0
0
19
204
0.93
0.07
1.0
1.1
8.37
8.41
u/ml
0.00
11
117
21
197
1.07
0.06
1.7
1.6
—
—
—
0
0
11
121
0.91
0.06
1.1
1.1
—
—
—
0
0
13
120
1.08
0.05
3.3
1.7
—
—
—
0
0
13
120
1.08
0.05
3.3
1.7
3.41
3.67
g/l
0.45
13
114
13
120
1.08
0.05
3.3
1.7
6.78
7.20
g/l
1.00
13
114
19
182
1.05
0.02
1.3
1.3
—
18.30
—
0
10
146
1470
0.99
0.01
1.6
1.5
—
—
—
0
0
15
144
1.04
0.00
1.8
1.3
116.20
103.29
u/ml
—
5
31
20
194
1.03
0.00
1.4
1.7
—
223.64
—
0
11
11
114
0.96
0.00
3.5
1.8
2.53
2.80
g/l
0.74
11
108
12
124
0.97
0.00
4.2
3.8
56.00
55.65
%
0.03
12
124
11
112
0.98
0.00
1.3
1.4
—
—
—
0
0
12
122
0.98
0.00
4.1
3.6
4.08
3.93
e9/l
0.12
12
122
138
1377
1.00
0.00
2.9
1.9
—
—
—
0
0
17
169
1.01
0.00
1.4
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
149.20
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
5.10
—
0
9
0
5
0.00
-0.00
0.0
2.2
—
13.56
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
10.78
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8.67
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_ANXPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ANXPER | 2.031 [1.64, 2.51] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.235 |
During the follow-up period (1.1.1998 — 31.12.2019), 110 out of 2540 females with F5_ANXPER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ANXPER | 2.306 [1.95, 2.72] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 215 out of 2580 males with F5_ANXPER died.
Mortality risk
Mortality risk for people of age
years, who have F5_ANXPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.19% | 0.533% |
| 5 | 1.135% | 2.685% |
| 10 | 2.929% | 6.836% |
| 15 | 5.855% | 13.274% |
| 20 | 10.102% | 22.534% |
Relationships between endpoints
↥Index endpoint: F5_ANXPER – Anxious personality disorder
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data